Julie Van Woensel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Julie Van Woensel has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- César Magro-Checa
Department of Rheumatology, Zuyderland Medical Center Heerlen Netherlands
3 shared publications Jasenko Krdzalic
Department of Radiology, Zuyderland Medical Centre, Heerlen/Sittard, the Netherlands
2 shared publications- Rémy L. M. Mostard
Zuyderland Medisch Centrum, afd. Longgeneeskunde, Heerlen
2 shared publications - Sofia Ramiro
Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Zuyderland Medical Center, Heerlen, the Netherlands
2 shared publications Bart Koopman
Department of Respiratory Medicine, OLVG, Amsterdam, The Netherlands
1 shared publicationCoen van Kan
Department of Respiratory Medicine, OLVG, Amsterdam, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 3 September 2026
- Published by European Respiratory Society (ERS) in ERJ Open Research
HRCT Phenotypes in Sarcoidosis: association with pulmonary function, inflammatory markers and organ involvement
STUDY QUESTION: Are the Delphi derived HRCT phenotypes associated with pulmonary function tests, inflammatory markers and organ involvement at presentation in newly diagnosed sarcoidosis patients? STUDY DESIGN AND METHODS: This cross-sectional study was conducted in two non-academic teaching hospitals between 2015 and 2020. Patients with a new diagnosis of sarcoidosis with baseline PFT and (HR)CT were included. CT images were systematically scored according to the Delphi HRCT phenotypes, including seven individual phenotypes (P1-P7) divided into two subgroups: “non-fibrotic” phenotypes (NFP) (P1-P4) and “likely-to-be fibrotic” phenotypes (FP) (P5-P7); and a “rest” group (not classifiable) and “null” group (no abnormalities) were identified. Differences in PFT, inflammatory markers and organ involvement were compared across phenotypes and subgroups. Logistic and linear regression was used to adjust for potential confounders. RESULTS: A total of 281 patients were included: 160 in the “NFP”, 34 in the “FP”, 8 in the “rest” and 79 in the “null” subgroup. Fibrotic phenotypes were associated with an obstructive pattern and diffusion impairment compared to NFP, with phenotypes P5 and 6 characterized by a restrictive spirometric pattern and moderate - severe diffusion impairment, and phenotype 7 characterized by an obstructive pattern and mild diffusion impairment. No consistent or clinically relevant associations were observed between CT phenotypes and inflammatory markers or organ involvement. ANSWER TO THE QUESTION: An association is for the first time demonstrated between the Delphi HRCT phenotypes and baseline PFT in newly diagnosed sarcoidosis, supporting the value of these phenotypes towards a more established CT classification.
- 3 September 2026
- Published by European Respiratory Society (ERS) in ERJ Open Research
Open AccessHRCT Phenotypes in Sarcoidosis: association with pulmonary function, inflammatory markers and organ involvement
STUDY QUESTION: Are the Delphi derived HRCT phenotypes associated with pulmonary function tests, inflammatory markers and organ involvement at presentation in newly diagnosed sarcoidosis patients? STUDY DESIGN AND METHODS: This cross-sectional study was conducted in two non-academic teaching hospitals between 2015 and 2020. Patients with a new diagnosis of sarcoidosis with baseline PFT and (HR)CT were included. CT images were systematically scored according to the Delphi HRCT phenotypes, including seven individual phenotypes (P1-P7) divided into two subgroups: “non-fibrotic” phenotypes (NFP) (P1-P4) and “likely-to-be fibrotic” phenotypes (FP) (P5-P7); and a “rest” group (not classifiable) and “null” group (no abnormalities) were identified. Differences in PFT, inflammatory markers and organ involvement were compared across phenotypes and subgroups. Logistic and linear regression was used to adjust for potential confounders. RESULTS: A total of 281 patients were included: 160 in the “NFP”, 34 in the “FP”, 8 in the “rest” and 79 in the “null” subgroup. Fibrotic phenotypes were associated with an obstructive pattern and diffusion impairment compared to NFP, with phenotypes P5 and 6 characterized by a restrictive spirometric pattern and moderate - severe diffusion impairment, and phenotype 7 characterized by an obstructive pattern and mild diffusion impairment. No consistent or clinically relevant associations were observed between CT phenotypes and inflammatory markers or organ involvement. ANSWER TO THE QUESTION: An association is for the first time demonstrated between the Delphi HRCT phenotypes and baseline PFT in newly diagnosed sarcoidosis, supporting the value of these phenotypes towards a more established CT classification.
- 29 August 2025
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 64 (12) , 6440-6441
Necrotizing granulomatous mass with skin and tracheal fistulization in ANCA-associated vasculitis
- 29 August 2025
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 64 (12) , 6440-6441
Necrotizing granulomatous mass with skin and tracheal fistulization in ANCA-associated vasculitis
- Open Access
- 27 December 2024
- Published by Oxford University Press (OUP) in BJR|Open
- Vol. 7 (1) , tzaf017
Radiological phenotypes in pulmonary sarcoidosis: a reliability study of newly defined high-resolution computer tomography phenotypes
Objectives: An accurate morphological classification of distinct pulmonary phenotypes in sarcoidosis is lacking. Recently, a multinational Delphi study was conducted to reach a consensus on recognizable high-resolution computer tomography (HRCT) phenotypes in pulmonary sarcoidosis as a basis for a more distinctive classification. The reliability of these phenotypes has not yet been evaluated. Methods: HRCT scans of adult sarcoidosis patients from the pulmonology department of a single sarcoidosis referral center were scored by three blinded independent readers. Seven phenotypes were distinguished as described in the Delphi study. They were divided into two subgroups: “non-fibrotic” and “likely-to-be fibrotic”. Intra- and inter-reader reliability for scoring the predominant phenotype and the subgroup was assessed using weighted Kappa (Kw) statistics. Results: Forty-five patients (mean age, 47 years ± 12, 28 men) were included. For the scoring of the predominant phenotype, inter-reader reliability between all readers was substantial with an overall Fleiss’ kappa of 0.69 (CI 0.622-0.765, P < .001). We observed a substantial inter-reader reliability between readers A and B (Kw of 0.76), between readers B and C (Kw of 0.66) and between readers A and C (Kw of 0.66). For the scoring of the subgroups “non-fibrotic” vs. “likely-to-be fibrotic,” overall Fleiss’ Kappa was substantial (K = 0.78, CI 0.607-0.944, P < .001). We observed a Kw score of 0.76 between readers A and B; 0.81 between readers A and C; 0.76 between readers B and C. Intra-reader reliability was substantial between the scores of A in scoring the predominant phenotypes (Kw of 0.71) and it was almost perfect in scoring the subgroups (Kw of 0.95). Intra-reader reliability was substantial between the scores of B in scoring the predominant phenotype (Kw of 0.66) and subgroups (Kw of 0.72). Conclusions: The inter- and intra-reader reliability of the newly proposed HRCT phenotypes obtained from the Delphi study is very acceptable. Advances in knowledge: This study is the first to assess the reliability of these HRCT phenotypes and supports the use of them for classification purposes in future clinical and pathogenetic studies.
- 27 December 2024
- Published by Oxford University Press (OUP) in BJR|Open
- Vol. 7 (1) , tzaf017
Open AccessRadiological phenotypes in pulmonary sarcoidosis: a reliability study of newly defined high-resolution computer tomography phenotypes
Objectives: An accurate morphological classification of distinct pulmonary phenotypes in sarcoidosis is lacking. Recently, a multinational Delphi study was conducted to reach a consensus on recognizable high-resolution computer tomography (HRCT) phenotypes in pulmonary sarcoidosis as a basis for a more distinctive classification. The reliability of these phenotypes has not yet been evaluated. Methods: HRCT scans of adult sarcoidosis patients from the pulmonology department of a single sarcoidosis referral center were scored by three blinded independent readers. Seven phenotypes were distinguished as described in the Delphi study. They were divided into two subgroups: “non-fibrotic” and “likely-to-be fibrotic”. Intra- and inter-reader reliability for scoring the predominant phenotype and the subgroup was assessed using weighted Kappa (Kw) statistics. Results: Forty-five patients (mean age, 47 years ± 12, 28 men) were included. For the scoring of the predominant phenotype, inter-reader reliability between all readers was substantial with an overall Fleiss’ kappa of 0.69 (CI 0.622-0.765, P < .001). We observed a substantial inter-reader reliability between readers A and B (Kw of 0.76), between readers B and C (Kw of 0.66) and between readers A and C (Kw of 0.66). For the scoring of the subgroups “non-fibrotic” vs. “likely-to-be fibrotic,” overall Fleiss’ Kappa was substantial (K = 0.78, CI 0.607-0.944, P < .001). We observed a Kw score of 0.76 between readers A and B; 0.81 between readers A and C; 0.76 between readers B and C. Intra-reader reliability was substantial between the scores of A in scoring the predominant phenotypes (Kw of 0.71) and it was almost perfect in scoring the subgroups (Kw of 0.95). Intra-reader reliability was substantial between the scores of B in scoring the predominant phenotype (Kw of 0.66) and subgroups (Kw of 0.72). Conclusions: The inter- and intra-reader reliability of the newly proposed HRCT phenotypes obtained from the Delphi study is very acceptable. Advances in knowledge: This study is the first to assess the reliability of these HRCT phenotypes and supports the use of them for classification purposes in future clinical and pathogenetic studies.